Long Noncoding RNA PVT1 Promotes EMT and Cell Proliferation and Migration Through Downregulating P21 in Pancreatic Cancer Cells

Bao-Qiang Wu,Yong Jiang,Feng Zhu,Dong-Lin Sun,Xiao-Zhou He
DOI: https://doi.org/10.1177/1533034617700559
2017-01-01
Technology in Cancer Research & Treatment
Abstract:BACKGROUND AND AIM:Long noncoding RNA-plasmacytoma variant translocation 1 is identified to be highly expressed and exhibits oncogenic activity in a variety of human malignancies, including pancreatic cancer. However, little is known about the overall biological role and mechanism of plasmacytoma variant translocation 1 in pancreatic cancer so far. In this study, we investigated the effect of plasmacytoma variant translocation 1 on pancreatic cancer cell proliferation and migration as well as epithelial-mesenchymal transition.METHODS:Pancreatic cancer tissue specimens and cell line were used in this study, with normal tissue and cell line acting as control.RESULTS:It showed that plasmacytoma variant translocation 1 expression was significantly upregulated in pancreatic cancer tissues or cell line compared to normal groups. Plasmacytoma variant translocation 1 downregulation significantly inhibited zinc finger E-box-binding protein 1/Snail expression but promoted p21 expression, and it also inhibited the cell proliferation and migration. Additionally, p21 downregulation enhanced, and p21 overexpression repressed, zinc finger E-box-binding protein 1/Snail expression and cells proliferation in PANC-1 cells. However, p21 downregulation reversed the effect of plasmacytoma variant translocation 1 downregulation on zinc finger E-box-binding protein 1/Snail expression and cell proliferation and migration.CONCLUSION:Plasmacytoma variant translocation 1 promoted epithelial-mesenchymal transition and cell proliferation and migration through downregulating p21 in pancreatic cancer cells.
What problem does this paper attempt to address?